Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-02-08
1980-07-08
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 232306, 252408, 424 14, 424 19, G01N 3316, A61K 4300
Patent
active
042117631
ABSTRACT:
In the determination of thyroid function in the triiodothyronine uptake and thyroxine tests, a tablet formed from a strongly basic anion exchange resin is used as a secondary binding agent to separate the bound and unbound radioactive thyroid hormone.
REFERENCES:
patent: 3768979 (1973-10-01), Mead et al.
patent: 3938953 (1976-02-01), Paschalis et al.
patent: 4015939 (1977-04-01), Lewin et al.
Murphy, J. of Lab. Clin. Med., vol. 66, #1, Jul. 1965, pp. 161-167.
Sterling et al., J. Clin. Endocrin., vol. 21, Apr. 1961, pp. 456-464.
Herndon William C.
Marshall David L.
Nucker Christine M.
Padgett Benjamin R.
The Dow Chemical Company
LandOfFree
Anion exchange resin in the determination of thyroid function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anion exchange resin in the determination of thyroid function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anion exchange resin in the determination of thyroid function will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-560454